Effect of race/ethnicity on risk, presentation and course of connective tissue diseases and primary systemic vasculitides

Current Opinion in Rheumatology

Volumn 24, Issue 2, 2012, Pages 193-200

  Piram, Maryam ^a,b   Maldini, Carla ^a   Mahr, Alfred ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

connective tissue disease; epidemiology; ethnicity; race; vasculitis

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANAPHYLACTOID PURPURA; ANCA ASSOCIATED VASCULITIS; BEHCET DISEASE; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; ETHNICITY; GIANT CELL ARTERITIS; GRANULOMATOSIS; HUMAN; MEDICAL RESEARCH; MICROSCOPIC POLYANGIITIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMYOSITIS; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SOCIOECONOMICS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VASCULITIS;

CONNECTIVE TISSUE DISEASES; DISEASE PROGRESSION; HUMANS; RISK; VASCULITIS;

EID: 84857054994     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32835059e5     Document Type: Review

References (87)

1. Lin SS, Kelsey JL. Use of race and ethnicity in epidemiologic research: Concepts, methodological issues, and suggestions for research. Epidemiol Rev 2000; 22:187-202. (Pubitemid 32116091)
2. Whaley AL. Ethnicity/race, ethics, and epidemiology. J Natl Med Assoc 2003; 95:736-742. (Pubitemid 37099527)
3. Jorde LB, Wooding SP. Genetic variation, classification and 'race'. Nat Genet 2004; 36:S28-S33.
4. Gibelin A, Maldini C, Mahr A. Epidemiology and etiology of Wegener granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and Goodpasture syndrome: Vasculitides with frequent lung involvement. Semin Respir Crit Care Med 2011; 32:264-273.
5. Fujimoto S, Watts RA, Kobayashi S, et al. Comparison of the epidemiology of antineutrophil cytoplasmic antibody-Associated vasculitis between Japan and the UK. Rheumatology (Oxford) 2011; 50:1916-1920. The study included first population-based prevalence and incidence survey for ANCA-Associated vasculitis overall from the Asian continent. The main findings are compared with those from an area in Eastern England.
6. Cao Y, Schmitz JL, Yang J, et al. DRB1-15 allele is a risk factor for PR3-ANCA disease in African Americans. J Am Soc Nephrol 2011; 22:1161-1167. First study to identify a race/ethnicity-specific genetic association for an AAV. The study also suggests a less favorable outcome with AAV-related renal disease among African Americans than whites.
7. Mahr A, Guillevin L, Poissonnet M, Ayme S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: A capture-recapture estimate. Arthritis Rheum 2004; 51:92-99. (Pubitemid 38222288)
8. Davatchi F, Shahram F, Chams-Davatchi C, et al. Behcet's disease: From East to West. Clin Rheumatol 2010; 29:823-833.
9. Papoutsis NG, Abdel-Naser MB, Altenburg A, et al. Prevalence of Adamantiades-Behcet's disease inGermany and the municipality of Berlin: Results of a nationwide survey. Clin Exp Rheumatol 2006; 24:S125. (Pubitemid 44696896)
10. Mahr A, Belarbi L, Wechsler B, et al. Population-based prevalence study of Behcet's disease: Differences by ethnic origin and low variation by age at immigration. Arthritis Rheum 2008; 58:3951-3959.
11. Krause I, Yankevich A, Fraser A, et al. Prevalence and clinical aspects of Behcet's disease in the north of Israel. Clin Rheumatol 2007; 26:555-560. (Pubitemid 46359297)
12. Calamia KT, Wilson FC, Icen M, et al. Epidemiology and clinical characteristics of Behcet's disease in the US: A population-based study. Arthritis Rheum 2009; 61:600-604.
13. Salvarani C, Pipitone N, Catanoso MG, et al. Epidemiology and clinical course of Behcet's disease in the Reggio Emilia area of Northern Italy: A seventeenyear population-based study. Arthritis Rheum 2007; 57:171-178.
14. de Menthon M, Lavalley MP, Maldini C, et al. HLA-B51/B5 and the risk of Behcet's disease: A systematic review and meta-Analysis of case-control genetic association studies. Arthritis Rheum 2009; 61:1287-1296.
15. Lewis KA, Graham EM, Stanford MR. Systematic review of ethnic variation in the phenotype of Behcet's disease. Scand J Rheumatol 2007; 36:1-6. (Pubitemid 46572905)
16. Prieto S, Grau JM. The geoepidemiology of autoimmune muscle disease. Autoimmun Rev 2010; 9:A330-A334.
17. Mastaglia FL, Phillips BA. Idiopathic inflammatory myopathies: Epidemiology, classification, and diagnostic criteria. Rheum Dis Clin North Am 2002; 28:723-741. (Pubitemid 36008549)
18. Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 2002; 360:1197-1202. (Pubitemid 35232718)
19. Peru H, Soylemezoglu O, Bakkaloglu SA, et al. Henoch Schönlein purpura in childhood: Clinical analysis of 254 cases over a 3-year period. Clin Rheumatol 2008; 27:1087-1092.
20. Gay C, Lavocat MP, Blanc JP. Incidence of rheumatoid purpura in children and frequency of associated nephropathy in the Loire region. Arch Pediatr 1997; 4:486-488.
21. Kawasaki Y, Suyama K, Yugeta E, et al. The incidence and severity of Henoch-Schönlein purpura nephritis over a 22-year period in Fukushima Prefecture, Japan. Int Urol Nephrol 2010; 42:1023-1029.
22. Ozen S, Bakkaloglu A, Dusunsel R, et al. Childhood vasculitides in Turkey: A nationwide survey. Clin Rheumatol 2007; 26:196-200. (Pubitemid 46020243)
23. Singh S, Aulakh R. Kawasaki disease and Henoch Schönlein purpura: Changing trends at a tertiary care hospital in north India (1993-2008). Rheumatol Int 2010; 30:771-774.
24. Cakir N, Pamuk ON, Donmez S. Henoch-Schönlein purpura in two brothers imprisoned in the same jail: Presentation two months apart. Clin Exp Rheumatol 2004; 22:235-237. (Pubitemid 38444817)
25. Monach PA, Merkel PA. Genetics of vasculitis. Curr Opin Rheumatol 2010; 22:157-163. Comprehensive review of the known genetic associations for various forms of systemic vasculitis.
26. Saulsbury FT. Henoch-Schönlein purpura. Curr Opin Rheumatol 2010; 22:598-602.
27. Huang WC, Huang LM, Chang IS, et al. Epidemiologic features of Kawasaki disease in Taiwan. Pediatrics 2009; 123:e401-e405.
28. Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan: Results of the 2007-2008 nationwide survey. J Epidemiol 2010; 20:302-307. 20th nationwide survey of Kawasaki disease in Japan providing the most recent epidemiologic features of the disease in the country with the highest incidence in the world.
29. Park YW, Han JW, Hong YM, et al. Epidemiological features of Kawasaki disease in Korea, 2006-2008. Pediatr Int 2011; 53:36-39.
30. Borzutzky A, Hoyos-Bachiloglu R, Cerda J, Talesnik E. Rising hospitalization rates of Kawasaki Disease in Chile between 2001 and 2007. Rheumatol Int 2011 (Epub ahead of print) DOI: 10.1007/s00296-011-2050-4.
31. Burgner D, Harnden A. Kawasaki disease: What is the epidemiology telling us about the etiology? Int J Infect Dis 2005; 9:185-194. (Pubitemid 40827159)
32. Piao JH, Jin LH, Lv J, et al. Epidemiological investigation of Kawasaki disease in Jilin province of China from 2000 to 2008. Cardiol Young 2010; 20:426-432.
33. Bar-Meir M, Haklai Z, Dor M. Kawasaki disease in Israel. Pediatr Infect Dis J 2011; 30:589-592.
34. Harnden A, Mayon-White R, Perera R, et al. Kawasaki disease in England: Ethnicity, deprivation, and respiratory pathogens. Pediatr Infect Dis J 2009; 28:21-24.
35. Holman RC, Belay ED, Christensen KY, et al. Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr Infect Dis J 2010; 29:483-488. This study describes the most recent epidemiologic features and trends of Kawasaki disease in the United States involving national estimates of Kawasaki disease-Associated hospitalizations.
36. Royle JA, Williams K, Elliott E, et al. Kawasaki disease in Australia, 1993-1995. Arch Dis Child 1998; 78:33-39.
37. Holman RC, Christensen KY, Belay ED, et al. Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med J 2010; 69:194-197. A study indicating that the incidence of Kawasaki disease in Japanese-American children is in the same range as that for Japanese living in Japan.
38. Ma XJ, Yu CY, Huang M, et al. Epidemiologic features of Kawasaki disease in Shanghai from 2003 through 2007. Chin Med J (Engl) 2010; 123:2629-2634.
39. Davis RL, Waller PL, Mueller BA, et al. Kawasaki syndrome in Washington State: Race-specific incidence rates and residential proximity to water. Arch Pediatr Adolesc Med 1995; 149:66-69.
40. Porcalla AR, Sable CA, Patel KM, et al. The epidemiology of Kawasaki disease in an urban hospital: Does African American race protect against coronary artery aneurysms? Pediatr Cardiol 2005; 26:775-781. (Pubitemid 43130169)
41. Son MB, Gauvreau K, Ma L, et al. Treatment of Kawasaki disease: Analysis of 27 US pediatric hospitals from 2001 to 2006. Pediatrics 2009; 124:1-8.
42. Onouchi Y, Gunji T, Burns JC, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 2008; 40:35-42.
43. Richards BL, March L, Gabriel SE. Epidemiology of large-vessel vasculidities. Best Pract Res Clin Rheumatol 2010; 24:871-883.
44. Kobayashi S, Yano T, Matsumoto Y, et al. Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: The first government-supported nationwide survey. Arthritis Rheum 2003; 49:594-598. (Pubitemid 36988315)
45. Pereira LS, Yoon MK, Hwang TN, et al. Giant cell arteritis in Asians: A comparative study. Br J Ophthalmol 2011; 95:214-216. Appraisal of the racial/ethnic characteristics of giant-cell arteritis strongly supporting the low disease risk among Asians living in the United States.
46. Smith CA, Fidler WJ, Pinals RS. The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum 1983; 26:1214-1219. (Pubitemid 13017177)
47. Lam BL, Wirthlin RS, Gonzalez A, et al. Giant cell arteritis among Hispanic Americans. Am J Ophthalmol 2007; 143:161-163. (Pubitemid 44917810)
48. Liu NH, LaBree LD, Feldon SE, Rao NA. The epidemiology of giant cell arteritis: A 12-year retrospective study. Ophthalmology 2001; 108:1145-1149. (Pubitemid 32500035)
49. Chaudhry IA, Shamsi FA, Elzaridi E, et al. Epidemiology of giant-cell arteritis in an Arab population: A 22-year study. Br J Ophthalmol 2007; 91:715-718. (Pubitemid 46846635)
50. Watts R, Al-Taiar A, Mooney J, et al. The epidemiology of Takayasu arteritis in the UK. Rheumatology (Oxford) 2009; 48:1008-1011.
51. Fox RI. Sjögren's syndrome. Lancet 2005; 366:321-331.
52. Alamanos Y, Tsifetaki N, Voulgari PV, et al. Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003. Rheumatology (Oxford) 2006; 45:187-191. (Pubitemid 43160081)
53. Birlik M, Akar S, Gurler O, et al. Prevalence of primary Sjögren's syndrome in Turkey: A population-based epidemiological study. Int J Clin Pract 2009; 63:954-961.
54. Goransson LG, Haldorsen K, Brun JG, et al. The point prevalence of clinically relevant primary Sjögren's syndrome in two Norwegian counties. Scand J Rheumatol 2011; 40:221-224.
55. Miyasaka N. Epidemiology and pathogenesis of Sjögren's syndrome. Nihon Rinsho 1995; 53:2367-2370.
56. Thomas E, Hay EM, Hajeer A, Silman AJ. Sjögren's syndrome: A communitybased study of prevalence and impact. Br J Rheumatol 1998; 37:1069-1076.
57. Tomsic M, Logar D, Grmek M, et al. Prevalence of Sjögren's syndrome in Slovenia. Rheumatology (Oxford) 1999; 38:164-170.
58. Zhang NZ, Shi CS, Yao QP, et al. Prevalence of primary Sjögren's syndrome in China. J Rheumatol 1995; 22:659-661.
59. Maldini C, Seror R, Fain O, et al. Epidé miologie du syndrome de Gougerot-Sjögren (SGS) primitif dans le dé partement de la Seine-Saint-Denis en 2007. Rev Méd Interne 2011; 32 (Suppl. 2):255. (abstract).
60. Maldini C, Seror R, Fain O, et al. Ethnic influences on the frequency and clinical-immunological features of primary Sjögren's syndrome (pSS) (abstract). Ann Rheum Dis 2011; 70 (Suppl. 3):297.
61. Pons-Estel GJ, Alarcon GS, Scofield L, et al. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 2010; 39:257-268. A review of the burden and patterns of disease of systemic lupus erythematosus and the influence and interactions of gender, ethnicity, age, and psychosocial attributes in terms of disease progression.
62. Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2002; 16:847-858.
63. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M. Morbidity of systemic lupus erythematosus: Role of race and socioeconomic status. Am J Med 1991; 91:345-353.
64. Osio-Salido E, Manapat-Reyes H. Epidemiology of systemic lupus erythematosus in Asia. Lupus 2010; 19:1365-1373.
65. Hart HH, Grigor RR, Caughey DE. Ethnic difference in the prevalence of systemic lupus erythematosus. Ann Rheum Dis 1983; 42:529-532. (Pubitemid 13016024)
66. Segasothy M, Phillips PA. Systemic lupus erythematosus in Aborigines and Caucasians in central Australia: A comparative study. Lupus 2001; 10:439-444. (Pubitemid 32578620)
67. Hopkinson ND, Doherty M, Powell RJ. The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989-1990. Br J Rheumatol 1993; 32:110-115. (Pubitemid 23077694)
68. Johnson AE, Gordon C, Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England: Relationship to ethnicity and country of birth. Arthritis Rheum 1995; 38:551-558.
69. Samanta A, Feehally J, Roy S, et al. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 1991; 50:490-492.
70. Anderson E, Nietert PJ, Kamen DL, Gilkeson GS. Ethnic disparities among patients with systemic lupus erythematosus in South Carolina. J Rheumatol 2008; 35:819-825. (Pubitemid 351747122)
71. Bastian HM, Roseman JM, McGwin G Jr., et al. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus 2002; 11:152-160. (Pubitemid 34296930)
72. Hochberg MC, Boyd RE, Ahearn JM, et al. Systemic lupus erythematosus: A review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) 1985; 64:285-295. (Pubitemid 16224044)
73. Neumann K, Wallace DJ, Azen C, et al. Lupus in the 1980s: III. Influence of clinical variables, biopsy, and treatment on the outcome in 150 patients with lupus nephritis seen at a single center. Semin Arthritis Rheum 1995; 25:47-55.
74. Patel M, Clarke AM, Bruce IN, Symmons DP. The prevalence and incidence of biopsy-proven lupus nephritis in the UK: Evidence of an ethnic gradient. Arthritis Rheum 2006; 54:2963-2969. (Pubitemid 44497777)
75. Seligman VA, Lum RF, Olson JL, et al. Demographic differences in the development of lupus nephritis: A retrospective analysis. Am J Med 2002; 112:726-729. (Pubitemid 34655662)
76. Krishnan E, Hubert HB. Ethnicity and mortality from systemic lupus erythematosus in the US. Ann Rheum Dis 2006; 65:1500-1505. (Pubitemid 44629130)
77. Fernandez M, Alarcon GS, Calvo-Alen J, et al. A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum 2007; 57:576-584. (Pubitemid 46764046)
78. Chifflot H, Fautrel B, Sordet C, et al. Incidence and prevalence of systemic sclerosis: A systematic literature review. Semin Arthritis Rheum 2008; 37:223-235.
79. Le Guern V, Mahr A, Mouthon L, et al. Prevalence of systemic sclerosis in a French multiethnic county. Rheumatology (Oxford) 2004; 43:1129-1137. (Pubitemid 39232818)
80. Laing TJ, Gillespie BW, Toth MB, et al. Racial differences in scleroderma among women in Michigan. Arthritis Rheum 1997; 40:734-742. (Pubitemid 27157581)
81. Mayes MD, Lacey JV Jr., Beebe-Dimmer J, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003; 48:2246-2255. (Pubitemid 36959206)
82. Arnett FC, Howard RF, Tan F, et al. Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma: Association with an Amerindian HLA haplotype. Arthritis Rheum 1996; 39:1362-1370. (Pubitemid 26270096)
83. Greidinger EL, Flaherty KT, White B, et al. African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease. Chest 1998; 114:801-807. (Pubitemid 28433744)
84. Beall AD, Nietert PJ, Taylor MH, et al. Ethnic disparities among patients with pulmonary hypertension associated with systemic sclerosis. J Rheumatol 2007; 34:1277-1282. (Pubitemid 46898109)
85. Kuwana M, Kaburaki J, Arnett FC, et al. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. Arthritis Rheum 1999; 42:465-474. (Pubitemid 29136094)
86. McNearney TA, Reveille JD, Fischbach M, et al. Pulmonary involvement in systemic sclerosis: Associations with genetic, serologic, sociodemographic, and behavioral factors. Arthritis Rheum 2007; 57:318-326. (Pubitemid 47164096)
87. Steen VD, Conte C, Owens GR, Medsger TA Jr. Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 1994; 37:1283-1289. (Pubitemid 24320744)